Digital-commerce-in-pharmaceuticals: Difference between revisions

A public knowledge platform on B2B digital commerce
No edit summary
No edit summary
Line 6: Line 6:
* McKinsey, 2022 [https://www.mckinsey.com/jp/en/our-insights/demystifying-the-omnichannel-commercial-model-for-pharma-companies-in-asia Demystifying the omnichannel commercial model for pharma companies in Asia]
* McKinsey, 2022 [https://www.mckinsey.com/jp/en/our-insights/demystifying-the-omnichannel-commercial-model-for-pharma-companies-in-asia Demystifying the omnichannel commercial model for pharma companies in Asia]
* European Pharmaceutical Review, 2020 [https://www.europeanpharmaceuticalreview.com/news/132881/lack-of-skill-and-talent-biggest-challenge-to-digital-transformation-in-pharma/ Lack of skill and talent biggest challenge to digital transformation in pharma]
* European Pharmaceutical Review, 2020 [https://www.europeanpharmaceuticalreview.com/news/132881/lack-of-skill-and-talent-biggest-challenge-to-digital-transformation-in-pharma/ Lack of skill and talent biggest challenge to digital transformation in pharma]
* Pharmaceutical Technology, 2022 [https://www.pharmaceutical-technology.com/features/insulin-pricing-could-an-e-commerce-approach-cut-costs/ Insulin pricing: could an e-commerce approach cut costs?]
*  Pharma manufacturing, 2022 [https://www.pharmamanufacturing.com/quality-risk/supply-chain/article/11414874/how-pharma-can-overcome-inflation How pharma can overcome inflation]





Revision as of 09:24, 26 March 2024